These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11690664)

  • 1. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels.
    Koh KK; Son JW; Ahn JY; Lee SK; Hwang HY; Kim DS; Jin DK; Ahn TH; Shin EK
    Int J Cardiol; 2001 Nov; 81(1):43-50. PubMed ID: 11690664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women.
    Koh KK; Jin DK; Yang SH; Lee SK; Hwang HY; Kang MH; Kim W; Kim DS; Choi IS; Shin EK
    Circulation; 2001 Apr; 103(15):1961-6. PubMed ID: 11306524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women.
    Koh KK; Shin MS; Sakuma I; Ahn JY; Jin DK; Kim HS; Kim DS; Han SH; Chung WJ; Shin EK
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1516-21. PubMed ID: 15166013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women.
    Sumino H; Ichikawa S; Ohyama Y; Takahashi T; Saito Y; Nakamura T; Kanda T; Kurabayashi M
    Am J Cardiol; 2005 Jul; 96(1):148-53. PubMed ID: 15979455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
    Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.
    McCrohon JA; Adams MR; McCredie RJ; Robinson J; Pike A; Abbey M; Keech AC; Celermajer DS
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):435-41. PubMed ID: 8959082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
    Christodoulakos GE; Lambrinoudaki IV; Economou EV; Papadias C; Vitoratos N; Panoulis CP; Kouskouni EE; Vlachou SA; Creatsas GC
    Atherosclerosis; 2007 Jul; 193(1):142-50. PubMed ID: 16842799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.
    Gebara OC; Mittleman MA; Sutherland P; Lipinska I; Matheney T; Xu P; Welty FK; Wilson PW; Levy D; Muller JE
    Circulation; 1995 Apr; 91(7):1952-8. PubMed ID: 7895352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
    Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
    Sumino H; Ichikawa S; Kanda T; Sakamaki T; Nakamura T; Sato K; Kobayashi I; Nagai R
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Vitale C; Gebara O; Mercuro G; Wajngarten M; Silvestri A; Rossini P; Ramires JA; Fini M; Rosano GM
    Maturitas; 2005 Apr; 50(4):239-46. PubMed ID: 15780522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide-dependent vasomotor function.
    Jokela H; Dastidar P; Rontu R; Salomäki A; Teisala K; Lehtimäki T; Punnonen R
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4348-54. PubMed ID: 12970309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women.
    Störk S; Baumann K; von Schacky C; Angerer P
    Cardiovasc Res; 2002 Feb; 53(3):642-9. PubMed ID: 11861035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
    Stark KD; Park EJ; Holub BJ
    Menopause; 2003; 10(5):448-55. PubMed ID: 14501607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
    Vural P; Akgul C; Canbaz M
    Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HRT decreases DNA and lipid oxidation in postmenopausal women.
    Escalante Gómez C; Quesada Mora S
    Climacteric; 2013 Feb; 16(1):104-10. PubMed ID: 22530644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
    Toth MJ; Sites CK; Matthews DE
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.